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Abstract 22 
Vegetarians are likely to have lower intakes of preformed docosahexaenoic acid (DHA) 23 
than omnivorous populations who consume fish and animal products. As such, vegetarian 24 
populations have omega-3 indices up to 60% lower than those who consume marine 25 
products. Algae, the primary producer of DHA in the marine food chain, offer an 26 
alternative source of DHA for those who do not consume marine or animal products. This 27 
systematic review aims to examine the evidence for the relationship between 28 
supplementation with algal forms of DHA and increased DHA concentrations in 29 
vegetarian populations. The SCOPUS, Science Direct and Web of Science scientific 30 
databases were searched to identify relevant studies assessing the effect of algal DHA 31 
consumption by vegetarian (including vegan) populations. Four randomized controlled 32 
trials and two prospective cohort studies met the inclusion criteria. All included studies 33 
reported algal sources of DHA significantly improve DHA concentrations (including 34 
plasma, serum, platelet, and red blood cell fractions) as well as omega-3 indices in 35 
vegetarian populations. An evident time or dose response was not apparent given the 36 
small number of studies to date. Future studies should address long chain n-3 37 
polyunsaturated fatty acid deficiencies in vegetarian populations using algal DHA and 38 
explore the potential physiological and health improvements in these individuals.  39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
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Introduction 51 
Vegetarian eating patterns are increasing in popularity as the associated health benefits 52 
become evident (1-3). Protection against chronic disease has been observed in those 53 
following a vegetarian eating pattern including coronary heart disease, hypertension, 54 
diabetes mellitus, obesity and some cancers 
(1, 2, 4)
. Eating patterns of this nature are 55 
typically higher in fruits and vegetables leading to increased oligo- and polysaccharides, 56 
fiber, and phytochemicals while being lower in saturated fat and cholesterol compared to 57 
omnivorous eating patterns (5, 6). Approaches to vegetarian eating range from the 58 
complete exclusion of animal products through to their inclusion at varying levels; eggs 59 
or dairy may be consumed 
(7)
 referred to as ovo- and lacto- forms of vegetarian eating, 60 
respectively. Individuals adhering to a vegan eating pattern exclude all products of an 61 
animal origin.  62 
Whilst many beneficial characteristics have been attributed to vegetarian eating patterns,  63 
vegetarian populations generally have lower plasma concentrations of docosahexaenoic 64 
acid (DHA; 22:6n-3; percentage of total fatty acids)
(8)
 and lower omega-3 indices 65 
compared to those who eat fish 
(9)
. The index is calculated using the sum of 66 
eicosapentaenoic acid (EPA; 22:5n-3) and DHA in erythrocyte membranes expressed as a 67 
percentage of total fatty acids 
(10)
. 68 
DHA is one of the two most prevalent polyunsaturated fatty acids in brain and retinal 69 
phospholipids (along with arachidonic acid), and plays a key role in normal 70 
neurotransmission 
(11)
 and visual function 
(12)
 and can be incorporated into cardiac 
(13)
 and 71 
skeletal muscle 
(14, 15)
. DHA is a long-chain omega-3 polyunsaturated fatty acid with a 72 
range of proposed health benefits including assisted foetal development 
(16)
, improved 73 
cardiovascular function (16, 17), reduced incidence of dementia (18), and improved cognitive 74 
functioning 
(11, 16)
.   75 
Vegetarian eating patterns are typically higher in alpha-linolenic acid (ALA), a precursor 76 
to DHA, compared to omnivorous eating patterns, however conversion of ALA to DHA 77 
is limited within the human body (9, 19). Several studies have reported varying conversion 78 
rates of ALA to DHA in humans, from no detectable conversion, to nine percent 79 
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conversion 
(20-22)
. Nonetheless, long-term vegetarian populations may have an increased 80 
capacity for synthesizing long chain omega-3 fatty acids (LCn-3FA) particularly DHA 81 
due to evolutionary pressures for improved ALA metabolism (23, 24). 82 
The richest dietary sources of DHA are fatty fish and seafood, however, fish are not the 83 
originators of DHA. Fish, like humans, do not readily synthesize DHA but feed on 84 
zooplankton which feeds on algae, the primary producer of the omega-3 DHA in the 85 
marine food chain (25).  Algae and algal supplements are rich in DHA, with some 86 
supplements containing no EPA at all 
(26)
. Human consumption of algal DHA rather than 87 
fish or seafood forms of DHA may provide adequate intakes of DHA for those who do 88 
not eat fish or seafood, although a consensus on the effect of algal supplementation on 89 
circulating DHA concentrations and incorporation into membranes has not been 90 
established.  91 
With the proposed health benefits and the limited research exploring the bioavailability of 92 
algal DHA compared to fish and fish oil, an important question arises: Does 93 
supplementation with algal forms of DHA in vegetarian populations improve their DHA 94 
concentrations? This review aims to address this question in relation to reported DHA 95 
fractions and/or omega-3 indices as markers of membrane incorporation.  96 
 97 
Methods 98 
 99 
Study protocol 100 
A systematic review of the literature was conducted using the SCOPUS, Science Direct 101 
and Web of Science scientific databases (all years to February 2016). The review was 102 
registered with PROSPERO, the international prospective register of systematic reviews 103 
(http://www.crd.york.ac.uk/PROSPERO, registration number CRD42015020724). The 104 
search strategy used the following keyword and Boolean combinations; “delta-6 105 
desaturase enzyme” OR “Docosahexaenoic Acid” OR DHA OR  “Omega 3”  OR  106 
“Eicosapentaenoic acid” OR  EPA  OR  “Linolenic acid”  OR  LA  OR  “Alpha-linoleic 107 
acid”  OR  ALA  OR  “Essential fatty acid”  OR  “α-Linolenic acid”  OR  “Omega 3 108 
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index” AND  vegetarian*  OR *vegetarian OR vegan* OR "plant-based" AND Human 109 
AND supplemen* in the article, keywords or abstract.  110 
Study selection 111 
 112 
Included publications met the following requirements: the studies (i) assessed the effect 113 
of consumption of algal sources of DHA in vegetarian (vegan, ovo-lacto-, ovo-, lacto-) 114 
populations aged 18 years or over, (ii) reported DHA fractions including plasma, serum, 115 
platelet, fat, RBC concentrations and/or omega-3 indices. Studies where vegetarian 116 
populations were included alongside omnivorous groups were included. Publications that 117 
met the following exclusion criteria were omitted: (i) not published in the English 118 
language, (ii) conference papers, short surveys, letters, notes, editorials, articles in press, 119 
book series, erratum and conference proceedings, (iii) intervention studies focused on 120 
fatty acids other than DHA (such as ALA, EPA), (iv) populations following a pesco-121 
vegetarian, flexitarian (plant-based eating patterns consuming fish or meat) or semi-122 
vegetarian eating pattern. Duplicate publications were removed using EndNote (version 123 
X7, 2013 Thomson Reuters; Philadelphia, Pennsylvania). Where results from the same 124 
study were reported in multiple publications, the first published study was included to 125 
avoid duplication of results. 126 
 127 
Screening of titles and abstracts was initially applied to exclude irrelevant papers, 128 
followed by retrieval of full-text publications. Reference lists of all included publications 129 
were also examined for relevant studies. Data extraction included information related to: 130 
the publication year, study design/quality, total sample size, population type, intervention 131 
and results. National Health and Medical Research Council levels of evidence 
(27)
 were 132 
applied to the included studies. Study quality was assessed using the quality criteria 133 
checklist of the Evidence Analysis Library (http://www.andeal.org/) of the Academy of 134 
Nutrition and Dietetics (2012) (28). 135 
 136 
 137 
 138 
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Results  139 
 140 
The literature search identified 695 publications (Figure 1). After duplicates were 141 
removed, 626 publications were excluded by title and abstract, while a further five were 142 
excluded following full text assessment. Seven publications (describing six studies) met 143 
the inclusion criteria, which included two prospective cohort studies and five intervention 144 
studies (Fig 1) 
(29-35)
. Two publications used the same data from one study and therefore 145 
the second publication (by date) was excluded (33) resulting in a total of six publications 146 
included in the review. All studies received positive scores after the quality criteria 147 
checklist of the Evidence Analysis Library study was applied 
(28)
 (data not shown). 148 
 149 
The doses of DHA provided via algal supplements ranged from 172 mg/day to 2.14 g/day 150 
in the included studies (Table 1). Five studies (30-32, 34, 35) investigated the effects of DHA 151 
supplementation on vegetarians with one study including vegans, exclusively 
(29)
. The 152 
study durations ranged from two weeks to four months with sample sizes ranging from 153 
twenty to 108 participants.  154 
 155 
DHA outcome measurements varied among studies and included serum total 156 
phospholipid (PL) DHA
(34) (31) (30)
, platelet total PL DHA
(31) (30)
, RBC total lipid DHA, 157 
RBC-phosphatidylethanolamine (RBC-PE) DHA, RBC-phosphatidylcholine (RBC-PC) 158 
DHA, plasma-PL DHA
(32)
, low-density lipoprotein (LDL) DHA concentrations 
(35)
 and 159 
omega-3 indices 
(29, 32)
. All included studies reported increases in serum, plasma, platelet 160 
and RBC DHA fractions and/or omega-3 indices following algal DHA supplementation. 161 
Increases in omega-3 indices were reported to range from 55% - 82% 
(29, 32)
 within groups 162 
supplemented with algal DHA. Similarly, DHA serum total phospholipids and platelet 163 
phospholipids were also elevated after algal supplementation, with increases ranging 164 
from 238% – 246% 
(30, 31)
, and 209 – 225% 
(30, 31)
 in total and platelet phospholipids 165 
respectively. The sole study exploring DHA plasma as a percentage of total fatty acids 166 
reported a 59% increase from baseline 
(34)
. Geppert et al 
(32)
 reported increases within 167 
groups in RBC total lipids (80% increase), RBC PE wt% (86% increase), RBC PC (174% 168 
increase) and plasma PL (164% increase) (p<0.001).  169 
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 170 
[Insert Figure 1 Here] 171 
 172 
[Insert Table 1 Here] 173 
 174 
Discussion 175 
 176 
The results of this review suggest that consumption of algal sources of DHA in 177 
vegetarian populations considerably increased levels of circulating DHA, including those 178 
measured in plasma, serum, platelet and RBC DHA fractions as well as omega-3 indices. 179 
This review highlights algal supplementation as a viable method of addressing the low 180 
DHA levels often seen in vegetarians and vegans 
(8, 9)
 however, given the varying doses, 181 
supplement periods and tissues, a clear dose response to recommend a threshold for 182 
effective increases in omega-3 status was not apparent. Providing DHA in the diet is 183 
clearly associated with positive health outcomes, including cardiovascular disease. As 184 
such, optimizing the tissue concentrations of DHA in vegetarian populations by using 185 
algal oil will be an important avenue of further research in nutrition translation and 186 
practice, and may also be relevant for omnivorous populations. 187 
 188 
When interpreting the results of this systematic literature review, it is important to note 189 
that while all included studies were assessed as being of positive quality, certain studies 190 
exhibited stronger methodology. Von Shacky et al 
(36)
 demonstrated that for 191 
cardiovascular protection to be observed as a health benefit of omega-3 fatty acids, 192 
evidence of tissue incorporation is required and study design is imperative. For example, 193 
Sarter et al 
(29)
 and Geppert et al 
(32)
 used a duration of four and two months, respectively, 194 
reporting both baseline and post-supplementation omega-3 indices, which provided a 195 
more rigorous depiction of algal supplementation in vegetarian populations. Conversely, 196 
four of the included studies (30, 31, 34, 35) reported the effects of short-term supplementation 197 
(two to six weeks) on serum total phospholipid DHA, platelet phospholipid DHA or 198 
LDL-DHA concentrations. The results may have been indicative of circulating 199 
concentrations and it is unclear if these elevated DHA concentrations would have been 200 
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incorporated into heart, skeletal muscle and brain tissue for health benefits to be 201 
observed.  202 
 203 
One included prospective cohort study 
(31)
 compared total phospholipid DHA in platelets 204 
between omnivorous and vegetarian populations after both groups were supplemented 205 
with algal oil. Similar increases in total phospholipid DHA were observed in both groups 206 
suggesting that algal oil supplementation has relevance for both omnivorous and 207 
vegetarian populations. Only one included study (34) explored the bioequivalence between 208 
fish oil and algal oil in a three-arm randomized controlled trial with no significant 209 
differences observed between groups. There appears to be a paucity of literature 210 
evaluating the efficacy between fish and algal forms of DHA, however from the limited 211 
human studies, it appears algal sourced DHA may have comparable bioavailability to fish 212 
sourced DHA (37, 38). Comparing algal DHA to fish DHA supplements is an area which 213 
warrants further investigation.  214 
 215 
Recently, concern has been expressed for omega-3 fatty acid controlled trials exploring 216 
cardiac outcomes 
(39, 40)
. Much of the criticism surrounds the disparity in study design 217 
when comparing standard pharmacological controlled trials to fish oil trials. In drug 218 
trials, the intervention is given to those in the experimental group, but not to those in the 219 
control group. In fish oil trials, both experimental and control groups are exposed to DHA 220 
due to background dietary intakes and baseline levels 
(39)
. Nonetheless, as this review 221 
explored DHA supplementation in vegetarian populations this flaw is somewhat negated 222 
as the control groups would theoretically be consuming none, or very small amounts of 223 
DHA and EPA. Furthermore, from a systems physiology perspective, there is no doubt 224 
that consumption of long chain omega-3 can provide support for optimizing heart 225 
function 
(17)
, however the translation of these benefits to a vegetarian population is 226 
currently unknown. A meta-analysis by Huang et al 
(41)
 showed vegetarians already have 227 
a 29% reduced risk of death from ischemic heart disease compared to omnivores, but 228 
there is a lack of research exploring if vegetarians would acquire even further protection 229 
with an increased omega-3 indices.  230 
 231 
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Algae and algal supplements tend to have a higher DHA to EPA ratio, with many 232 
supplements containing no EPA 
(26)
. Thus, this review focused on the effect of algal 233 
supplements on DHA levels, however the increased levels of DHA observed in the 234 
studies in this review may also have additional benefits on other fatty acids. 235 
Supplementation with DHA may result in improved EPA concentrations via retro-236 
conversion from DHA to EPA. For instance, Conquer and Holub 
(30)
 used an EPA-free 237 
preparation of DHA which was supplemented daily by an omnivorous group and 238 
vegetarian group. DHA concentrations (serum and platelet PL) significantly increased in 239 
both groups, as did EPA via retro-conversion of DHA to EPA. The increase in serum PL 240 
EPA concentration was 9.4% overall with no significant difference between omnivores 241 
and vegetarians. EPA has been linked to favorable health characteristics, such as 242 
cardiovascular protection 
(42) 
and reduced inflammation 
(43)
. Given that EPA 243 
concentrations (plasma PL) have also been reported to be significantly lower in 244 
vegetarian populations when compared to groups who consume moderate to large 245 
amounts of meat 
(44)
, supplementation with algal DHA may provide an alternate method 246 
of increasing EPA levels for those who do not consume fish.  247 
 248 
While this review has provided insight into the effect of algal DHA supplementation in 249 
vegetarians, there are some limitations. Large double-blinded randomized controlled 250 
trials measuring baseline and post-supplementation omega-3 indices with algal forms of 251 
DHA would be beneficial to substantiate these results. Publication bias may also have 252 
influenced the results of this review. Regardless of the limitations, the findings were 253 
consistent across studies with all six included studies reporting increases in various 254 
plasma and serum fractions and/or erythrocyte LDL-DHA concentrations and/or omega-3 255 
indices across a range of doses and intervention durations.  256 
 257 
Conclusion 258 
 259 
This review consolidated existing studies and has reported that supplementing with algal 260 
forms of DHA can increase an array of serum and platelet DHA concentrations and 261 
omega-3 indices in vegetarians. This finding is relevant given that this population is 262 
10 
 
known to have lower serum and plasma DHA concentrations than omnivorous 263 
individuals. Further research is warranted to determine appropriate algal DHA threshold 264 
doses / supplement durations to achieve clinically relevant elevations in omega-3 indices. 265 
Additionally, research investigating if there are grounds for DHA supplementation in 266 
vegetarian populations, which may potentially further optimize their cardiac protection 267 
and reduce chronic disease, is indicated. 268 
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 Table 1. Summary of included studies using algal DHA supplementation.  
 
Reference  Study design 
(Level of  
evidence) 
Sample  
size 
Duration of 
vegetarianism/Population 
Age (mean + SD 
or range), years 
DHA dose 
/day, mg 
Duration, 
weeks 
Study results  DHA 
outcomes 
Sarter et al  
(2015)(29) 
Prospective Cohort 
(III – 2) 
n = 46 
- minimum 1 year vegan          
 
- omega-3 index < 4% 
 
 
 
22 - 85 
172 16 
- Omega-3 index ↑ 3.1% ± 
0.6% to 4.8% ± 0.8 ⇞  
Increased 
Conquer & 
Holub 
(1997)(31) 
Prospective Cohort 
(III – 2)  
 
n = 20 
 
 
- minimum 6 months 
vegetarian (ovo, ovo-lacto or 
lacto) 
 
 
 
26.8 ± 1.6 1620 
 
6 
- DHA serum total PL ↑from 
2.1 ± 0.2 to 7.1± 0.4 mol% ‡   
 
- DHA Platelet PL ↑from 1.1± 
0.1 to 3.4± 0.2 mol% ‡  
Increased 
Ryan & 
Symington 
(2014)(34) 
A 
pseudorandomised 
controlled trial (III-
1) 
 
 
n = 12 
 
 
- duration not reported ∆ 
 
- vegetarian (ovo, ovo-lacto or 
lacto) and/or vegan  
 
 
 
 
 
18 - 65 
200   2 
 
- DHA plasma (% of total fatty 
acids)↑2.76 ± 1.13 to 5.08 ± 
0.45 ‡  
Increased 
Conquer & 
Holub 
(1996)(30) 
RCT (II) 
 
n = 24 
 
- minimum 6 months 
vegetarian (ovo, ovo-lacto or 
lacto) 
 
 
 
29.6 ± 1.7 1620 *  6 
- DHA serum total PL ↑from 
2.4 ± 0.2 to 8.3 ± 0.2 g/100g  ‡ 
 
- DHA platelet PL↑ from 1.2 ± 
0.1 to 3.9 ± 0.2 g/100g  ‡ 
Increased 
Geppert et 
al 
(2005)(32) 
RCT (II) 
 
 
n = 108 
 
 
 
- minimum 1 year vegetarian 
(ovo, ovo-lacto or lacto) 
 
 
 
 
 
 
 
 
 
 
 
25.9 ± 5.6 
 940 †  8 
- Omega 3 index ↑from 4.8 to 
8.4wt% ⇞ ↡ 
 
- DHA RBC total lipids↑from 
4.4± 0.2 to 7.9 ± 0.2 wt% ⇞ ↡ 
 
- DHA RBC PE↑from 6.5 ± 
0.3 to 12.1 ± 0.3 wt   
⇞ ↡ 
 
- DHA RBC PC↑from 1.38 ± 
0.07 to 3.78 ± 0.13 ⇞ ↡ 
 
- DHA Plasma PL↑from 2.8 ± 
0.1 to 7.4 ± 0.2 wt% ⇞ ↡ 
Increased 
Wu et al 
 (2006)(35) 
RCT (II) n = 25 
 
- minimum 1 year vegan 
and/or lacto-ovo-vegetarian  
 
52.3 ±5.1 
(control group) 
52.6 ±4.4 
(intervention 
group) 
2140 *  6  
 
- LDL-DHA↑from 1.35± 0.54 
to 3.71 ± 1.03 ↡   
Increased 
- Prospective Cohort study, (III-2) - Non-randomised, experimental trial. 
- Pseudorandomised controlled Trial (III-1) - Alternate allocation or some other method. 
- RCT (Randomized Controlled Trial; II) - A study of test accuracy with: an independent, blinded comparison with a valid 
reference standard, among consecutive patients with a   defined clinical presentation. 
* Control – Corn Oil, † Control – Olive Oil, 
∆ Other study arms described in study – Nil control 
⇞ Significant within group (p<0.001) 
‡ Significant within group (p<0.05) 
↡ Significant between control group (p<0.001) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The PRISMA flowchart showing the initial and final number of studies 
obtained. 
Records identified through 
Scopus, Science Direct & Web 
of Science databases (n = 695) 
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Additional records identified 
through other sources (n = 0) 
Records after duplicates removed via 
endnote (n = 637) 
Titles and abstract 
screened (n = 637) 
Records excluded 
(n = 626) 
Full-text articles 
assessed for eligibility 
(n = 11) 
Full-text articles excluded, 
Population not met (n=2) 
Intervention not met (n=2) 
Duplicate study results (n=1) 
Total studies included 
(n = 6) 
